The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
Open accessAbstract
INTRODUCTION: Many psychotropic drugs can delay cardiac repolarization and thereby prolong the rate-corrected QT interval (QTc). A prolonged QTc often arouses concern in clinical practice, as it can be followed, in rare cases, by the life-threatening polymorphic ventricular tachyarrhythmia called torsade de pointes (TdP). METHOD: We searched PubMed for pertinent literature on the risk of QTc prolongation and/or TdP associated with commonly used psychotropic drugs. RESULTS: Thioridazine and ziprasidone confer the highest risk of QTc prolongation and/or TdP. There is also a clinically significant risk associated with haloperidol given intravenously in high doses. TdP has been reported in a few cases in association with the use of newer antipsychotic drugs (mainly quetiapine and amisulpride), most of the tri- and tetracyclic antidepressants, and the selective monoamine reuptake inhibitors citalopram, fluoxetine, paroxetine, and venlafaxine. As a rule, however, QTc prolongation and/or TdP occur only in the presence of multiple additional risk factors, such as age over 65 years, pre-existing cardiovascular disease, bradycardia, female sex, hypokalemia, hypomagnesemia, a supratherapeutic or toxic serum concentration, or the simultaneous administration of other drugs that delay repolarization or interfere with drug metabolism. CONCLUSION: Before prescribing a psychotropic drug, the physician should carefully assess its risks and benefits to avoid this type of adverse reaction, particularly when additional risk factors are present. The ECG and electrolytes should be regularly monitored in patients taking psychotropic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
Haddad, P. M., & Anderson, I. M. (2002) · Drugs · doi:10.2165/00003495-200262110-00006 · Cited by 435
Mechanism of Hypokalemia in Magnesium Deficiency
Huang, C.-L., & Kuo, E. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070792 · Cited by 431
Harrigan, E. P., Miceli, J. J., Anziano, R., Watsky, E., Reeves, K. R., Cutler, N. R., Sramek, J., Shiovitz, T., & Middle, M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104913.75206.62 · Cited by 363
Gupta, A., Lawrence, A. T., Krishnan, K., Kavinsky, C. J., & Trohman, R. G. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.040 · Cited by 362
QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial
Wedam, E. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2469 · Cited by 259
Torsades de Pointes Associated With Intravenous Haloperidol in Critically Ill Patients
Sharma, N. D., Rosman, H. S., Padhi, I. D., & Tisdale, J. E. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00888-6 · Cited by 232
Magnesium therapy for torsades de pointes
Tzivoni, D., Keren, A., Cohen, A. M., Loebel, H., Zahavi, I., Chenzbraun, A., & Stern, S. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90025-0 · Cited by 226
Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults
Wernicke, J. F., Faries, D., Girod, D., Brown, J. W., Gao, H., Kelsey, D., Quintana, H., Lipetz, R., Michelson, D., & Heiligenstein, J. (2003) · Drug Safety · doi:10.2165/00002018-200326100-00006 · Cited by 191
QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Alvarez, P., & Pahissa, J. (2010) · Current Drug Safety · doi:10.2174/157488610789869265 · Cited by 173
De Ponti, F., Poluzzi, E., & Montanaro, N. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100290 · Cited by 171
Antipsychotic drugs and QT prolongation
Stöllberger, C., Huber, J. O., & Finsterer, J. (2005) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000166405.49473.70 · Cited by 168
Tricyclic Antidepressants, QT Interval Prolongation, and Torsade de Pointes
Vieweg, W. V. R., & Wood, M. A. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.5.371 · Cited by 150
Wernicke, J., Lled, A., Raskin, J., Kajdasz, D. K., & Wang, F. (2007) · Drug Safety · doi:10.2165/00002018-200730050-00007 · Cited by 147
Möller, H., Volz, H., Reimann, I. W., & Stoll, K.-D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00011 · Cited by 147
Sala, M., Vicentini, A., Brambilla, P., Montomoli, C., Jogia, J., Caverzasi, E., Bonzano, A., Piccinelli, M. P., Barale, F., & Ferrari, G. M. D. (2005) · Annals of General Psychiatry · doi:10.1186/1744-859x-4-1 · Cited by 145
Psychotropic drugs and the ECG: focus on the QTc interval
Goodnick, P. J., Parra, F., & Jerry, J. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.5.479 · Cited by 139
Poluzzi, E., Raschi, E., Moretti, U., & Ponti, F. D. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1746 · Cited by 138
Aripiprazole: profile on efficacy and safety
Goodnick, P. J., & Jerry, J. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.12.1773 · Cited by 130
QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia
Ozeki, Y., Fujii, K., Kurimoto, N., Yamada, N., Okawa, M., Aoki, T., Takahashi, J. A., Ishida, N., Horie, M., & Kunugi, H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.008 · Cited by 128
Psychotropic Drugs Associated With Corrected QT Interval Prolongation
van Noord, C., Straus, S. M. J. M., Sturkenboom, M., Albert Hofman, D., Aarnoudse, A. L. H. J., Bagnardi, V., Kors, J. A., Newton‐Cheh, C., Witteman, J. C. M., & Stricker, B. H. C. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318191c6a8 · Cited by 125
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects
Dixon, R. M., Job, S., Oliver, R., Tompson, D. J., Wright, J. G., Maltby, K., Lorch, U., & Täubel, J. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03250.x · Cited by 112
Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs
Vieweg, W. V. R., Wood, M. A., Fernandez, A., Beatty-Brooks, M., Hasnain, M., & Pandurangi, A. K. (2009) · Drugs & Aging · doi:10.2165/11318880-000000000-00000 · Cited by 110
Substitution of (R,S)-Methadone by (R)-Methadone
Ansermot, N. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.26 · Cited by 110
Drug‐induced torsades de pointes: a review of the Swedish pharmacovigilance database
Åström‐Lilja, C., Odeberg, J. M., Ekman, E., & Hägg, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1607 · Cited by 92
Reddy, S., Hui, D., Osta, B. E. E., de la Cruz, M., Walker, P. J., Palmer, J. L., & Bruera, E. D. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.0184 · Cited by 88
QTc Interval, CYP2D6 and CYP2C9 Genotypes and Risperidone Plasma Concentrations
LLerena, A., Berecz, R., Dorado, P., et al. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042618 · Cited by 83
Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest
Tarabar, A. F., Hoffman, R. S., & Nelson, L. S. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160963 · Cited by 72
Amisulpride Overdose Is Frequently Associated With QT Prolongation and Torsades de Pointes
Isbister, G. K., Balit, C. R., Macleod, D., & Duffull, S. B. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e5c14c · Cited by 66
Justo, D., Gal‐Oz, A., Paran, Y., Goldin, Y., & Zeltser, D. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01512.x · Cited by 60
QT Effects of Duloxetine at Supratherapeutic Doses: A Placebo and Positive Controlled Study
Zhang, L., Chappell, J., Gonzales, C., Small, D. S., Knadler, M. P., Callaghan, J. T., Francis, J. L., Desaiah, D., Leibowitz, M. T., Ereshefsky, L., et al. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318030aff7 · Cited by 58
Raskin, J., Wiltse, C. G., Dinkel, J. J., Walker, D. J., Desaiah, D., & Katona, C. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160738e · Cited by 57
QT interval prolongation associated with venlafaxine administration
Letsas, Κ. P., Korantzopoulos, P. G., Pappas, L. K., Evangelou, D., Efremidis, M., & Kardaras, F. G. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.03.065 · Cited by 57
Paliperidone ER: a review of the clinical trial data
Janicak, P. G. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1365 · Cited by 54
Investigation of the Potential of Clozapine to Cause Torsade de Pointes
Warner, B., & Hoffmann, P. (2002) · Adverse Drug Reactions and Toxicological Reviews · doi:10.1007/bf03256196 · Cited by 53
H1 antihistamine drug promethazine directly blocks hERG K+ channel
Jo, S., Hong, H.-K., Chong, S. H., Lee, H. S., & Choe, H. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.05.008 · Cited by 52
Citalopram induced torsade de pointes, a rare life threatening side effect
Kanjanauthai, S., Kanluen, T., & Chareonthaitawee, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.006 · Cited by 51
Prolonged QTc intervals in medicated patients with schizophrenia
Chong, S. A., Mythily, Lum, A., Goh, H. Y., & Chan, Y. H. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.540 · Cited by 49
Vieweg, W. V. R., Schneider, R. K., & Wood, M. A. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00592.x · Cited by 47
Hoehns, J. D., Stanford, R. H., Geraets, D. R., Skelly, K., Lee, H. C., & Gaul, B. L. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.9.871.34565 · Cited by 40
Amitriptyline-induced torsade de pointes. Successful therapy with atrial pacing
Davison, E. T. (1985) · Journal of Electrocardiology · doi:10.1016/s0022-0736(85)80055-8 · Cited by 38
Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder1
Simpson, D., & Plosker, G. L. (2004) · CNS Drugs · doi:10.2165/00023210-200418060-00011 · Cited by 37
Lack of effect of reboxetine on cardiac repolarization
Fleishaker, J. C. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117705 · Cited by 33
Citalopram-induced long QT syndrome and torsade de pointes: Role for concomitant therapy and disease
GREGORIO, C. D., Morabito, G., Cerrito, M., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.060 · Cited by 30
The potential for QT prolongation by antiepileptic drugs in children
Kwon, S., Lee, S.-B., Hyun, M.-C., Choe, B., Kim, Y. H., Park, W., & Cho, Y. (2004) · Pediatric Neurology · doi:10.1016/s0887-8994(03)00405-3 · Cited by 30
Antipsychotikainduzierte QT-Verlängerung
Haverkamp, W., & Deuschle, M. (2005) · Der Nervenarzt · doi:10.1007/s00115-005-1966-x · Cited by 29
Prevalence of hypomagnesemia (HM) in a geriatric long-term care (LTC) setting
Arinzon, Z. H., Peisakh, A., Schrire, S., et al. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.07.002 · Cited by 28
Negrao, B. L., Crafford, D., & Viljoen, M. (2009) · Europe PMC (PubMed Central) · Cited by 23
Duloxetine in the treatment of generalized anxiety disorder
Norman, T. R., & Olver, J. S. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2820 · Cited by 20
Antidepressant efficacy and cardiac safety of trimipramine in patients with mild heart disease.
Cohn, J. B., Wilcox, C. S., & Goodman, L. (1993) · PubMed · Cited by 19
Electrocardiographic effects of methylphenidate overdose
Hill, S. L., El-Khayat, R. H., Sandilands, E. A., & Thomas, S. H. L. (2010) · Clinical Toxicology · doi:10.3109/15563651003720234 · Cited by 17
Leponex®, 10 ans après – Une revue clinique
Llorca, P., & Péré, J.-J. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95462-0 · Cited by 17
Medikamentös induzierte Verlängerung des QT-Intervalls
Altmann, D., Eggmann, U., & Ammann, P. (2008) · Wiener klinische Wochenschrift · doi:10.1007/s00508-008-0940-6 · Cited by 17
Prolonged QT Associated With an Overdose of Trazodone
Dattilo, P., & Nordin, C. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0821e · Cited by 15
QT-Verlängerung und Torsade de pointes-Tachykardie bei Therapie mit Maprotilin
Lentini, S., Rao, M. L., Schröder, R., Lüderitz, B., & Bauriedel, G. (2001) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2001-18880 · Cited by 12
Medikamenten-assoziiertes Long-QT-Syndrom
Bruggisser, Bravo, R., & Bodmer (2009) · Praxis · doi:10.1024/1661-8157.98.24.1409 · Cited by 10
Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning
Chang, J., Weng, T., & Fang, C. (2009) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.11.014 · Cited by 5
Lohse, M. J., & Müller-Oerlinghausen, B. (2010) · Springer eBooks · doi:10.1007/978-3-642-13380-0_39 · Cited by 5
Cited by
Electrophysiology of Hypokalemia and Hyperkalemia
Weiss, J. N., Qu, Z., & Shivkumar, K. (2017) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004667 · Cited by 404
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.11.001 · Cited by 345
Comprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 310
Vieweg, W. V. R., Hasnain, M., Howland, R. H., Hettema, J. M., Kogut, C., Wood, M. A., & Pandurangi, A. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.12.002 · Cited by 270
Metadata
- Authors
- Wenzel-Seifert, K., Wittmann, M., & Haen, E.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2011-10-14
- Volume
- 108
- Issue
- 41
- Pages
- 687-93
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W2102426258
- Cited by
- 256
- References
- 59
- FWCI
- 10.46
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.